Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Histamine-2 receptor antagonists and risk of lung cancer in diabetic patients - an exploratory analysis
 
  • Details

Histamine-2 receptor antagonists and risk of lung cancer in diabetic patients - an exploratory analysis

Resource
Pharmacoepidemiol. Drug Saf., 22(6), 632-640
Journal
Pharmacoepidemiol. Drug Saf.
Journal Volume
22
Journal Issue
6
Pages
632
Date Issued
2013-06
Date
2013
Author(s)
CHIA-LIN HSU  
CHIA-HSUIN CHANG  
JOU-WEI LIN  
Wu, Li-Chiu
LEE-MING CHUANG  
Lai, Mei-Shu
DOI
10.1002/pds.3441
URI
http://ntur.lib.ntu.edu.tw//handle/246246/259368
https://www.scopus.com/record/display.uri?eid=2-s2.0-84878785379&doi=10.1002%2fpds.3441&origin=inward&txGid=fd2b958a9669523e92eaceb101cc8ba8
Abstract
Purpose Histamine-2 receptor blockers (H2RBs) might have anti-tumorogenic effect, but the clinical effect on lung cancer occurrence was unclear. Methods A total of 640,173 type 2 diabetic patients were identified from the Taiwan National Health Insurance claims database in 2000. Patients were followed from cohort entry to the earliest of cancer diagnosis, death, disenrollment from the national health insurance, or 31 December 2007. For each participant, H2RB use during the follow-up period was ascertained from the outpatient pharmacy prescription database. Patients with incident squamous cell carcinoma (SCC) and adenocarcinoma were included as cases and up to four age- and sex-matched controls were selected by risk-set sampling. Conditional logistic regression models were applied to estimate the association between H2RBs and lung cancer incidence. Results A total of 1182 incident SCC and 2345 adenocarcinoma cases were identified, and 13,108 matched controls were selected. An increased risk was observed for H2RBs use <1year with adjusted OR of 1.33 (95% confidence interval (CI): 1.22-1.44). After excluding all exposures occurring in the year before lung cancer diagnosis, H2RBs use with cumulative dosage360 defined daily doses was associated with a significantly decreased risk of lung cancer (OR: 0.60; 95% CI: 0.38-0.96). When we stratified on types of lung cancer, the protective association of higher cumulative use of H2RBs seemed more evident for lung adenocarcinoma, with an adjusted OR of 0.49 (95% CI: 0.26-0.90). Conclusions Higher cumulative use of H2RBs might be associated with a reduced risk for non-small cell lung cancer in diabetic patients. Copyright (c) 2013 John Wiley & Sons, Ltd.
Subjects
histamine H2 antagonists
lung neoplasms
diabetes mellitus
nested case-control studies
pharmacoepidemiology
SDGs

[SDGs]SDG3

Type
journal article
File(s)
Loading...
Thumbnail Image
Name

index.html

Size

23.15 KB

Format

HTML

Checksum

(MD5):78f969a62141b6784e02875c53c61438

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science